Siemens Healthineers to buy US cancer specialist for $16.4 bn
Siemens Healthineers, the German conglomerate's medical devices arm, said Sunday it has agreed to buy US cancer treatment specialist Varian for $16.4 billion.
Aug 2, 2020
0
4
Siemens Healthineers, the German conglomerate's medical devices arm, said Sunday it has agreed to buy US cancer treatment specialist Varian for $16.4 billion.
Aug 2, 2020
0
4
Facing competition for the world's top-selling drug, AbbVie is jumping on this year's pharmaceutical merger bandwagon with a $63 billion bid for Botox maker Allergan that's meant to spur future growth.
Jun 25, 2019
0
0
Drug giant Pfizer says it won't split into two publicly traded companies, despite pressure from investors frustrated by its lagging stock price, ending years of Wall Street speculation over its strategy and future.
Sep 26, 2016
0
1
The drugmaker Merck is paying $830 million to resolve a federal class-action lawsuit involving shareholders and the painkiller Vioxx, which was pulled from the market years ago over safety concerns.
Jan 15, 2016
0
0
Shareholders of the drugmaker Perrigo shut the door on a $26-billion hostile takeover bid from Mylan.
Nov 13, 2015
0
3
Shares of Mylan are edging up before the opening bell after the pharmaceutical company went ahead with its hostile, $27.14 billion bid for Perrigo.
Sep 15, 2015
0
4
Pharmaceutical company Mylan said Tuesday that it would take its offer to buy Perrigo directly to Perrigo shareholders following refusals by the company's management to engage in merger talks.
Sep 8, 2015
0
7
The drugmaker AbbVie has reached a deal worth roughly $55 billion to combine with British counterpart Shire and become the latest U.S. company to seek an overseas haven from tax rates back home.
Jul 18, 2014
0
0
Allergan, the maker of Botox, said Monday that Valeant Pharmaceuticals' hostile takeover bid for the company is "grossly inadequate" and that shareholders should reject it.
Jun 23, 2014
0
0
Valeant Pharmaceuticals said Wednesday it has launched a tender offer for Allergan, the maker of Botox, taking its hostile bid directly to shareholders.
Jun 18, 2014
0
0
A mutual shareholder or stockholder is an individual or company (including a corporation) that legally owns one or more shares of stock in a joint stock company. A company's shareholders collectively own that company. Thus, the typical goal of such companies is to enhance shareholder value.
Stockholders are granted special privileges depending on the class of stock. These rights may include:
However, stockholder's rights to a company's assets are subordinate to the rights of the company's creditors. This means that stockholders typically receive nothing if a company is liquidated after bankruptcy (if the company had had enough to pay its creditors, it would not have entered bankruptcy), although a stock may have value after a bankruptcy if there is the possibility that the debts of the company will be restructured.
Stockholders or shareholders are considered by some to be a partial subset of stakeholders, which may include anyone who has a direct or indirect equity interest in the business entity or someone with even a non-pecuniary interest in a non-profit organization. Thus it might be common to call volunteer contributors to an association stakeholders, even though they are not shareholders.
Although directors and officers of a company are bound by fiduciary duties to act in the best interest of the shareholders, the shareholders themselves normally do not have such duties towards each other.
However, in a few unusual cases, some courts have been willing to imply such a duty between shareholders. For example, in California, majority shareholders of closely held corporations have a duty to not destroy the value of the shares held by minority shareholders.
The largest shareholders (in terms of percentage owned of companies) are often mutual funds, especially passively managed exchange-traded funds[citation needed].
Shareholders play an important role in raising capital for organizations. So these figures pose a great opportunity for all those who are looking for a lucrative option to invest money. Companies typically provide all the necessary proofs to shareholders to show that they are investing at a right place. For example, fair and reliable audit figures from income statement and balance sheet are used as evidence of overall performance for the benefit of shareholders.
This text uses material from Wikipedia, licensed under CC BY-SA